企業プロフィール
ProMIS Neurosciences 株価・ニュース・カタリスト
- ティッカー:
- PMN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Canada and listed in the U
株価パフォーマンス
14.66 USD (-1.35%)
終値
最終更新: 2026年8月17日
91M USD
時価総額
株価変動の要因
As of Aug 17, 2026, PMN closed down 1.35% at $14.66. No new same-company headline was identified in the current news window.
企業概要
Misfolded Protein Therapeutics
ProMIS Neurosciences develops antibodies that selectively recognize toxic misfolded protein species implicated in neurodegenerative disease.
PMN310
PMN310 targets toxic amyloid-beta oligomers while seeking to avoid binding monomers and plaque, potentially reducing off-target immune effects.
PRECISE-AD
The fully enrolled Phase 1b PRECISE-AD study evaluates PMN310 in patients with Alzheimer’s disease using safety, imaging, and biomarker measures.
今後のカタリスト
- Twelve-month unblinded topline results from the Phase 1b PRECISE-AD study of PMN310 in the first quarter of 2027.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。